These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1775731)

  • 1. Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II).
    Lembcke B; Lamberts R; Wöhler J; Creutzfeldt W
    Res Exp Med (Berl); 1991; 191(6):389-404. PubMed ID: 1775731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal glycogen storage mimicking the cytological picture of Pompe's disease as induced in rats by injection of an alpha-glucosidase inhibitor. I. Alterations in liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(1):89-100. PubMed ID: 6119839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R; Taylor JA
    Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal glycogen accumulation in rat liver and its in vivo kinetics after a single intraperitoneal injection of acarbose, an alpha-glucosidase inhibitor.
    Konishi Y; Okawa Y; Hosokawa S; Fujimori K; Fuwa H
    J Biochem; 1990 Feb; 107(2):197-201. PubMed ID: 2193931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
    Reuser AJ; Wisselaar HA
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():19-24. PubMed ID: 8001622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a.
    Bollen M; Vandebroeck A; Stalmans W
    Biochem Pharmacol; 1988 Mar; 37(5):905-9. PubMed ID: 2964235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbance of lysosomal glycogen metabolism by liposomal anti-alpha-glucosidase and some anti-inflammatory drugs.
    Geddes R; Otter DE; Scott GK; Taylor JA
    Biochem J; 1983 Apr; 212(1):99-103. PubMed ID: 6347194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal glycogen storage mimicking the cytological picture of Pompe's disease as induced in rats by injection of an alpha-glycosidase inhibitor. II. Alterations in kidney, adrenal gland, spleen and soleus muscle.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 39(2):187-202. PubMed ID: 6123191
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
    Joubert PH; Venter HL; Foukaridis GN
    Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
    Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
    Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the metabolic control of cytosolic and lysosomal glycogen levels in the liver.
    Geddes R; Taylor JA
    Biosci Rep; 1985 Apr; 5(4):315-20. PubMed ID: 3896336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid alpha-glucosidases in human fibroblasts and HepG2 cells.
    Wisselaar HA; van Dongen JM; Reuser AJ
    Clin Chim Acta; 1989 Jun; 182(1):41-52. PubMed ID: 2546700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of miglitol and acarbose on starch digestion, daily plasma glucose profiles and cataract formation.
    Madar Z; Hazan A
    J Basic Clin Physiol Pharmacol; 1993; 4(1-2):69-81. PubMed ID: 8679512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pseudotetrasaccharide acarbose inhibits pancreatic islet glucan-1,4-alpha-glucosidase activity in parallel with a suppressive action on glucose-induced insulin release.
    Salehi A; Panagiotidis G; Borg LA; Lundquist I
    Diabetes; 1995 Jul; 44(7):830-6. PubMed ID: 7789651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post mortem glycogenolysis is a combination of phosphorolysis and hydrolysis.
    Calder PC; Geddes R
    Int J Biochem; 1990; 22(8):847-56. PubMed ID: 2279618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive responses to pharmacological inhibition of small intestinal alpha-glucosidases in the rat.
    Lembcke B; Löser C; Fölsch UR; Wöhler J; Creutzfeldt W
    Gut; 1987; 28 Suppl(Suppl):181-7. PubMed ID: 3319810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.
    Ladas SD; Frydas A; Papadopoulos A; Raptis SA
    Gut; 1992 Sep; 33(9):1246-8. PubMed ID: 1427379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acarbose is a competitive inhibitor of mammalian lysosomal acid alpha-D-glucosidases.
    Calder PC; Geddes R
    Carbohydr Res; 1989 Aug; 191(1):71-8. PubMed ID: 2776140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
    Madar Z
    J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.